Family history of Alzheimer disease (AD) is associated with several age-related changes that appear to influence AD biomarker abnormalities beyond the increased risk of the APOE4 gene, according to a report published in the October issue of Archives of Neurology. Previously, researchers suspected that AD has a lengthy preclinical period prior to the development of symptoms, in which cerebral lesions accumulate.